Clin2
NCT07375862Possibly a fitNot yet recruiting

Danhong Injection for Sepsis-Related Heart Problems

Sepsis-Induced Myocardial Dysfunction

Part of Heart & circulation, Infections clinical trials.

This study tests if Danhong Injection, a Chinese herbal medicine, can help people whose heart function is weakened by a serious infection (sepsis). The injection aims to protect heart cells and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a serious infection that has caused your heart to pump less effectively (sepsis-induced heart dysfunction).
  • You are not already taking Danhong Injection or other medications that strongly affect your heart.
  • You do not have severe liver or kidney disease.
  • You are not allergic to any ingredients in Danhong Injection.
  • You are not pregnant or breastfeeding.
  • You have not taken part in another drug trial in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686355Recruiting· Phase 2
Yiqilishui formula for sepsis-related heart problems

This trial tests a Chinese herbal formula called Yiqilishui in people with sepsis who have developed heart muscle weakness. It aims to see if the formula can help improve heart function.

Beijing
NCT06898723Recruiting· Phase 4
Shenfu injection to prevent heart problems in sepsis

This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.

Wuhu, Anhui
NCT06920420Not yet recruiting
Testing a new biomarker for Xuebijing injection in sepsis

This study looks at a Chinese herbal injection called Xuebijing to see if certain biomarkers can predict how well it works for sepsis patients. It may help find new ways to treat sepsis more effectively.

NCT06514339Recruiting· Early Phase 1
Shenhuang granules for sepsis treatment

This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.

Hangzhou, Zhejiang
NCT06915506Not yet recruiting· Phase 4
Can Shenfu injection help blood vessels in septic shock?

This trial tests whether Shenfu injection can improve the flexibility of blood vessels in people with severe infections (sepsis or septic shock). It may help understand how to better support the heart and circulation during critical illness.

Wuhu, Anhui
NCT07603024Not yet recruiting
Shenfu Injection for Septic Shock Blood Flow Problems

This study tests whether a traditional Chinese medicine injection (Shenfu) can improve blood flow and organ function in patients with septic shock—a life-threatening infection where the body's blood pressure drops dangerously low despite fluids. Researchers want to see if this treatment helps the heart pump blood more effectively to vital organs.

Wuhu, Anhui

Hear when a new Sepsis Induced Myocardial Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.